Evelyn Partners Investment Management LLP Has $3.10 Million Stock Position in Colgate-Palmolive Company $CL

Evelyn Partners Investment Management LLP raised its stake in Colgate-Palmolive Company (NYSE:CL) by 2,611.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,248 shares of the company’s stock after acquiring an additional 33,948 shares during the quarter. Evelyn Partners Investment Management LLP’s holdings in Colgate-Palmolive were worth $3,095,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Grimes & Company Inc. raised its position in shares of Colgate-Palmolive by 1.0% during the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after acquiring an additional 118 shares during the last quarter. RFG Advisory LLC boosted its stake in shares of Colgate-Palmolive by 1.4% in the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after purchasing an additional 123 shares during the last quarter. Tiemann Investment Advisors LLC grew its position in shares of Colgate-Palmolive by 2.1% during the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock worth $553,000 after buying an additional 125 shares during the period. Redhawk Wealth Advisors Inc. lifted its holdings in Colgate-Palmolive by 2.4% in the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock valued at $497,000 after buying an additional 129 shares during the period. Finally, Westside Investment Management Inc. boosted its stake in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL opened at $80.97 on Friday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The firm has a fifty day simple moving average of $78.73 and a 200 day simple moving average of $84.84. The stock has a market capitalization of $65.27 billion, a price-to-earnings ratio of 22.74, a PEG ratio of 4.44 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 EPS. Research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 17th were paid a dividend of $0.52 per share. The ex-dividend date was Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CL shares. Morgan Stanley decreased their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, October 8th. Barclays decreased their target price on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. The Goldman Sachs Group cut their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a report on Friday, October 10th. Nine analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $89.87.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.